Company: SCLXW
Filing Date: 2025-11-04
Form Type: 424B3
Source: 0001193125-25-264319
Chunk: 30

Company: Scilex Holding Co
Filing Date: 2025-11-04
Form: 424B3
Chunk 30
---
via-medtech---ivd-solution-brochure.pdf

Navigating the Future of In Vitro Diagnostics by IQVIA (Published September 27, 2024). Covers IVD market evolution in 2024, driven by tech and regulations.

URL: https://www.iqvia.com/blogs/2024/09/navigating-the-future-of-in-vitro-diagnostics

In Vitro Diagnostics Market Size, Share | Industry Report, 2030 by Grand View Research. Estimates 2024 at USD 108.30 billion with projections to 2030.

URL: https://www.grandviewresearch.com/industry-analysis/in-vitro-diagnostics-ivd-market

In-vitro Diagnostics Market Size, Growth Outlook 2025–2034 by Global Market Insights. 2024 estimate at USD 105.7 billion, with growth to 2025 and beyond.

URL: https://www.gminsights.com/industry-analysis/in-vitro-diagnostics-market

In Vitro Diagnostics Market Growth, Drivers, and Opportunities by MarketsandMarkets. 2024 at $101.06 billion, 2025 at $109.07 billion, with 7.6% CAGR.

URL: https://www.marketsandmarkets.com/Market-Reports/ivd-in-vitro-diagnostics-market-703.html

<div align='center'>Page |39</div>

In-vitro Diagnostics [IVD] Market Size, Trends | Growth, 2032 by Fortune Business Insights. Projections from 2025 at $77.73 billion to 2032.

URL: https://www.fortunebusinessinsights.com/industry-reports/in-vitro-diagnostics-ivd-market-101443

In Vitro Diagnostics - Worldwide | Statista Market Forecast. Forecasted revenue of US$92.03 billion by 2025.

URL: https://www.statista.com/outlook/hmo/medical-technology/in-vitro-diagnostics/worldwide

In Vitro Diagnostics Market Size & Outlook, 2026-2034 by Straits Research. 2024 at USD 82.98 billion, 2025 at USD 86.51 billion.

URL: https://straitsresearch.com/report/in-vitro-diagnostics-market

# # #

SEMDEXA™ (SP-102) is a trademark owned by Semnur Pharmaceuticals, Inc., a majority-owned subsidiary of Scilex